核受体NR6A1通过重编程瘤中的葡萄糖分解起到致癌作用
Xiaowen Liu1, Ye Li2, Xinxu Rao2
1Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, 410007, China.
核受体NR6A1通过重编程糖解促进肺腺癌. 抑制NR6A1通过miR-302a/HK1通路抑制癌细胞生长,葡萄糖消耗和ATP产生.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 核受体NR6A1作为一个转录抑制剂.
- NR6A1与前列腺癌,胃癌和丸癌的进展有关.
- 它在肺腺癌中的作用需要进一步阐明.
研究的目的:
- 研究NR6A1在肺腺癌中的致癌作用.
- 阐明NR6A1影响瘤细胞代谢和生长的分子机制.
- 在NR6A1信号通路中识别潜在的治疗点.
主要方法:
- 在肺腺癌细胞系 (HeLa,TFK1,A549) 中的NR6A1倒退.
- 评估细胞增殖,葡萄糖消耗,乳酸生产,ATP水平和线粒体膜潜力.
- 生物信息学分析,双露西法酶记者基因测定,RT-qPCR和西部斑分析.
- 功能性救援实验以验证机械学的发现.
主要成果:
- 抑制NR6A1显著降低了肺腺癌细胞增殖,葡萄糖吸收,乳酸生产,ATP水平和线粒体膜潜力.
- 发现NR6A1抑制了miR-302a的表达,导致HK1的表达增加.
- 这种NR6A1介导的糖解重编程增强了肺腺癌细胞的生长.
- NR6A1还影响mTOR信号传递,表明它在瘤代谢中起着更广泛的作用.
结论:
- NR6A1在肺腺癌中起着关键的致癌作用.
- 致癌功能通过NR6A1/miR-302a/HK1轴进行介导,该轴重编程瘤细胞糖解.
- NR6A1代表了肺腺癌治疗的潜在治疗标.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
相关概念视频
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Introduction to Nuclear Reprogramming
